ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
11.07
+0.39 (3.65%)
At close: Oct 19, 2026, 4:00 PM EDT
10.93
-0.14 (-1.26%)
After-hours: Oct 19, 2026, 7:30 PM EDT

ADMA Biologics Revenue

ADMA Biologics had revenue of $124.40M in the quarter ending June 30, 2026, with 1.98% growth. This brings the company's total for the last twelve months to $512.28M, up 8.04% year-over-year. In the year 2025, ADMA Biologics had annual revenue of $510.17M with 19.63% growth. That makes ADMA Biologics the 11,079th largest company in the world by revenue and 2,273rd in the United States.

Revenue (ttm)
$512.28M
Revenue Growth
+8.04%
P/S Ratio
4.84
Revenue / Employee
$791,770
Employees
647
Market Cap
2.48B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • ADMA BioManufacturing 493.00M 96.6%
  • Plasma Collection Centers 17.03M 3.3%
  • License 143.00K 0.0%

By Geography

Chart
  • United States 504.07M 98.8%
  • International 6.11M 1.2%
Fiscal year ended Dec 31, 2025 See the full ADMA Biologics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025510.17M83.72M19.63%
Dec 31, 2024426.45M168.24M65.15%
Dec 31, 2023258.22M104.14M67.59%
Dec 31, 2022154.08M73.14M90.36%
Dec 31, 202180.94M38.72M91.72%
Dec 31, 202042.22M12.87M43.85%
Dec 31, 201929.35M12.36M72.79%
Dec 31, 201816.99M-5.78M-25.37%
Dec 31, 201722.76M12.10M113.49%
Dec 31, 201610.66M3.48M48.53%
Dec 31, 20157.18M1.26M21.34%
Dec 31, 20145.92M2.85M92.84%
Dec 31, 20133.07M1.95M174.35%
Dec 31, 20121.12M357.08K46.92%
Dec 31, 2011761.04K--
Jun 30, 2011---
Dec 31, 2010---
Jun 30, 2010---
Jun 30, 2009---
Jun 30, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.